bpc-157 fda warning september 2025 Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Doctors warn of risks tied
Description
P.Sikiric, M.Petek, R.Rucman, I.Rotkvic et al, Exp.Clin
Many of the products now being advertised or sold online are not approved by the Therapeutic Goods Administration (TGA), meaning they havent been assessed for safety, quality or effectiveness
Additionally, PEA could be a potential alternative for loading candidate peptides aimed at treating OA
This information can be invaluable for your healthcare provider, helping them make informed adjustments to your treatment plan
